Humana Inc.:企業の戦略・SWOT・財務情報

◆英語タイトル:Humana Inc. - Strategy, SWOT and Corporate Finance Report
◆商品コード:DATA904C1926
◆発行会社(調査会社):MarketLine
◆発行日:2018年7月
◆ページ数:61
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD175 ⇒換算¥25,900見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD350 ⇒換算¥51,800見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD525 ⇒換算¥77,700見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はMarketLine社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
MarketLine社の概要はこちらでご確認いただけます。



【レポートの概要】

Humana Inc. – Strategy, SWOT and Corporate Finance Report
Summary

Humana Inc. – Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company’s structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company.

Key Highlights

Humana Inc. (Humana or ‘the company’) is one of the leading providers of insurance products and health and wellness services. It offers products and services for individual and family including life insurance, medical plans, vision plans, dental plans, and life and supplemental plans, among others. Humanais headquartered in Louisville, Kentucky, the US.

Scope

- Detailed information on Humana Inc. required for business and competitor intelligence needs
- A study of the major internal and external factors affecting Humana Inc. in the form of a SWOT analysis
- An in-depth view of the business model of Humana Inc. including a breakdown and examination of key business segments
- Intelligence on Humana Inc.’s mergers and acquisitions (MandA), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
- News about Humana Inc., such as business expansion, restructuring, and contract wins
- Large number of easy-to-grasp charts and graphs that present important data and key trends

Reasons to buy

- Gain understanding of Humana Inc. and the factors that influence its strategies.
- Track strategic initiatives of the company and latest corporate news and actions.
- Assess Humana Inc. as a prospective partner, vendor or supplier.
- Support sales activities by understanding your customers’ businesses better.
- Stay up to date on Humana Inc.’s business structure, strategy and prospects.

【レポートの目次】

Table of Contents
Company Snapshot 2
Table of Contents 5
Humana Inc.: Company Overview 9
Humana Inc.: Overview and Key Facts 9
Humana Inc.: Overview 9
Humana Inc.: Key Facts 9
Humana Inc.: Key Employees 10
Humana Inc.: Key Employee Biographies 12
Humana Inc.: Major Products and Services 19
Humana Inc.: Company History 20
Humana Inc.: Management Statement 26
Humana Inc.: Locations and Subsidiaries 31
Humana Inc.: Key Competitors 32
Humana Inc.: Company Analysis 33
Humana Inc.: Business Description 33
Humana Inc.: SWOT Analysis 34
Humana Inc.: SWOT Overview 34
Humana Inc.: Strengths 34
Humana Inc.: Weaknesses 35
Humana Inc.: Opportunities 35
Humana Inc.: Threats 36
Humana Inc.: Corporate Financial Deals Activity 37
Humana Inc.: Financial Deals Overview 37
Humana Inc.: Targets and Partners 39
Humana Inc.: Top Deals 2014 – 2018YTD* 40
Humana Inc.: Advisors 41
Humana Inc.: Top Legal Advisors 41
Humana Inc.: Top Financial Advisors 41
Humana Inc.: Mergers and Acquisitions 43
Humana Inc.: Corporate Venturing 44
Humana Inc.: Capital Raising 45
Humana Inc.: Partnership 46
Humana Inc.: Divestments 47
Humana Inc.: Recent Developments 48
Humana Inc.: News and Events Summary 48
Humana Inc.: Contracts 53
Humana Inc.: Corporate Governance 57
Humana Inc.: Strategy and Operations 57
Appendix 59
Contact Us 59
Methodology 59
About MarketLine 60

List of Tables
Table 1: Humana Inc.: Key Facts
Table 2: Humana Inc.: Key Employees
Table 3: Humana Inc.: Locations and Subsidiaries
Table 4: Humana Inc.: Key Competitors
Table 5: Humana Inc.: Deal Activity by Deal Type - Volume (TTM*)
Table 6: Humana Inc.: M&A Activity by Geography (TTM*)
Table 7: Humana Inc.: Deal Activity by Deal Type - Volume (2014 - YTD*2018)
Table 8: Humana Inc.: M&A Average Deal Size - Value (US$m)
Table 9: Humana Inc.: Targets and Partners
Table 10: Humana Inc.: Top Deals 2014 - 2018YTD*
Table 11: Humana Inc.: Legal Advisor Ranking by Value (US$m)
Table 12: Humana Inc.: Financial Advisor Ranking by Value (US$m)
Table 13: Humana Inc.: M&A Volume and Value Trend (2014 - YTD*2018)
Table 14: Humana Inc.: M&A Activity by Geography (2014 - YTD*2018)
Table 15: Humana Inc.: Corporate Venturing Volume and Value Trend (2014 - YTD*2018)
Table 16: Humana Inc.: Corporate Venturing by Geography (2014 - YTD*2018)
Table 17: Humana Inc.: Capital Raising Volume and Value Trend (2014 - YTD*2018)
Table 18: Humana Inc.: Capital Raising by Deal Type (2014 - YTD*2018)
Table 19: Humana Inc.: Partnership Volume and Value Trend (2014 - YTD*2018)
Table 20: Humana Inc.: Partnership Trend by Deal Type (2014 - YTD*2018)
Table 21: Humana Inc.: Divestments Volume and Value Trend (2014 - YTD*2018)
Table 22: Humana Inc.: Divestments by Geography (2014 - YTD*2018)
Table 23: Humana Inc.: News and Events Summary
Table 24: Humana Inc.: Contracts
Table 25: Humana Inc.: Corporate Governance
Table 26: Humana Inc.: Strategy and Operations

List of Figures
Figure 1: Humana Inc.: Deal Activity by Deal Type - Volume (TTM*)
Figure 2: Humana Inc.: M&A Activity by Geography (TTM*)
Figure 3: Humana Inc.: Deal Activity by Deal Type - Volume (2014 - YTD*2018)
Figure 4: Humana Inc.: M&A Average Deal Size - Value (US$m)
Figure 5: Humana Inc.: M&A Volume and Value Trend (2014 - YTD*2018)
Figure 6: Humana Inc.: M&A Activity by Geography (2014 - YTD*2018)
Figure 7: Humana Inc.: Corporate Venturing Volume and Value Trend (2014 - YTD*2018)
Figure 8: Humana Inc.: Corporate Venturing by Geography (2014 - YTD*2018)
Figure 9: Humana Inc.: Capital Raising Volume and Value Trend (2014 - YTD*2018)
Figure 10: Humana Inc.: Capital Raising by Deal Type (2014 - YTD*2018)
Figure 11: Humana Inc.: Partnership Volume and Value Trend (2014 - YTD*2018)
Figure 12: Humana Inc.: Partnership Trend by Deal Type (2014 - YTD*2018)
Figure 13: Humana Inc.: Divestments Volume and Value Trend (2014 - YTD*2018)
Figure 14: Humana Inc.: Divestments by Geography (2014 - YTD*2018)

★海外企業調査レポート[Humana Inc.:企業の戦略・SWOT・財務情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • StageZero Life Sciences Ltd (GEN):企業の財務・戦略的SWOT分析
    Summary StageZero Life Sciences Ltd (StageZero Life Sciences) is a provider of molecular diagnostic products. The company develops and commercializes diagnostics and personalized medicine for cancer and other chronic diseases. Its Sentinel Principle is a novel approach to identifying biomarkers of b …
  • Peters Surgical:医療機器:M&Aディール及び事業提携情報
    Summary Peters Surgical (Peters), a subsidiary of Eurazeo SA, is a medical device company that designs, manufactures and distributes surgical products. The company offers products such as catheters, sutures, surgical glue, cardiac ring, single use instrument and accessories for surgical procedures. …
  • Haitong Securities Co., Ltd.:企業の戦略・SWOT・財務分析
    Haitong Securities Co., Ltd. - Strategy, SWOT and Corporate Finance Report Summary Haitong Securities Co., Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …
  • T2 Biosystems Inc (TTOO):企業の製品パイプライン分析
    Summary T2 Biosystems Inc (T2 Biosystems) is a provider of clinical diagnostic products in the field of in vitro diagnostics. The company’s T2 magnetic resonance technology allows direct detection in complex samples such as whole blood, serum, plasma, sputum and urine. T2 Biosystems offers T2HemoSta …
  • equensWorldline SE:企業の戦略・SWOT・財務情報
    equensWorldline SE - Strategy, SWOT and Corporate Finance Report Summary equensWorldline SE - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Revera Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Revera Inc (Revera), formerly Retirement Residences Real Estate Investment Trust, is a healthcare service provider that offers assisted living, independent living, seniors’ apartments,memory care and long term care services. The center provides person-centered care, quality care, clinical pr …
  • Fenwal Inc-医療機器分野:企業M&A・提携分析
    Summary Fenwal Inc (Fenwal), a subsidiary of Fresenius Kabi AG is a blood technology company that supports transfusion medicine and cell therapies. The company’s products include amicus separator, blood pack units with whole blood filter, mononuclear cell collection, alyx component collection system …
  • Reynard Corp:企業の戦略・SWOT・財務分析
    Reynard Corp - Strategy, SWOT and Corporate Finance Report Summary Reynard Corp - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate a …
  • Pioneer Energy Services Corp (PES):企業の財務・戦略的SWOT分析
    Pioneer Energy Services Corp (PES) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and w …
  • ADInstruments Pty Ltd:企業の戦略的SWOT分析
    ADInstruments Pty Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and …
  • Targa Resources Corp.:企業の戦略・SWOT・財務情報
    Targa Resources Corp. - Strategy, SWOT and Corporate Finance Report Summary Targa Resources Corp. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • NIKE Inc:戦略・SWOT・企業財務分析
    NIKE Inc - Strategy, SWOT and Corporate Finance Report Summary NIKE Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, …
  • Opsens Inc (OPS):医療機器:M&Aディール及び事業提携情報
    Summary Opsens Inc (Opsens), formerly DCB Capital Inc, is a provider of fiber optic sensing technology solutions. The company focuses on fractional flow reverse guidewire in interventional cardiology. It offers OptoWire, an optical-based pressure guidewire, which enhances the clinical outcome of pat …
  • TapImmune Inc (TPIV):企業の財務・戦略的SWOT分析
    Summary TapImmune Inc (TapImmune) is a clinical-stage immuno-oncology company focus on the development of innovative peptide, gene-based immunotherapeutics and vaccines for the treatment of cancer and metastatic disease. The company’s pipeline products include TPIV 200, which is intended for the tre …
  • Hitachi Medical Systems America Inc-医療機器分野:企業M&A・提携分析
    Summary Hitachi Medical Systems America Inc (Hitachi Medical), a subsidiary of Hitachi Healthcare Manufacturing Ltd is a provider of diagnostic imaging equipment. The company offers MRI, CT, ultrasound, optical topography and x-ray equipment. Its services comprise construction assistance, rigging as …
  • Invivo Corp-医療機器分野:企業M&A・提携分析
    Summary Invivo Corp (Invivo), a subsidiary of Koninklijke Philips NV is a medical device company that designs, manufactures, and markets patient monitoring systems. The company offers products in various categories such as advanced visualization systems, breast imaging and biopsy solutions, neuro im …
  • Aurora Diagnostics LLC:製薬・医療:M&Aディール及び事業提携情報
    Summary Aurora Diagnostics LLC (Aurora Diagnostics) is a healthcare service provider that offers hospital and pathology services. The center’s pathology services include gastrointestinal pathology services, heamato-pathology services, dermatology services, urologic pathology, pathology consultation, …
  • Ardelyx Inc (ARDX):企業の財務・戦略的SWOT分析
    Summary Ardelyx Inc (Ardelyx) is a developer of small molecule therapeutics for treatment of cardio-renal, gastrointestinal and metabolic disorders. The company offers products such as tenapanor, and RDX013. Its products are used for hyperphosphatemia in patients with end-stage renal disease; consti …
  • Kura Oncology Inc (KURA):企業の財務・戦略的SWOT分析
    Summary Kura Oncology Inc (Kura Oncology) is a clinical-stage biopharmaceutical company that discovers and develops therapeutics for the treatment of solid tumors and blood cancers. The company’s lead drug candidate Tipifarnib, an inhibitor of farnesyl transferase, an oral investigational drug candi …
  • City Utilities of Springfield:発電所・企業SWOT分析
    City Utilities of Springfield - Power Plants and SWOT Analysis, 2017 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on key …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆